Pre-market hot trades in US stocks: Cloudflare pre-market up 3.13%, AI new features and security collaboration boost market confidence

Pre-market Hot Trades in US Stocks CloudFlare is up 3.13% in pre-market trading. Based on recent key news: On April 14, Cloudflare announced the launch of the Agent Cloud feature, promoting AI agent development. This move led to a 9% increase in stock price, reflecting the market's positive response to its AI strategy. Source: WSJ On April 14, Cloudflare partnered with Wiz to launch an AI security solution, further solidifying its position in the cybersecurity field. This collaboration boosted investor confidence, driving the stock price up. Source: Business Wire On April 13, analysts maintained a "Buy" rating on Cloudflare, raising the target price to $265, indicating market recognition of its long-term growth potential. Source: Citigroup AI technology is driving transformation in the cybersecurity industry. Top Gainers in Pre-market US Stocks Allied Gaming & Entertainment is up 97.38% in pre-market trading. Based on recent key news: On April 14, Allied Gaming & Entertainment announced a comprehensive solution and strategic development path with Knighted Pastures. This move resolved all pending issues between the two parties and closed previous legal proceedings, significantly boosting the stock price. Source: Reuters On April 14, Allied Gaming & Entertainment released an announcement detailing its strategic cooperation with Knighted Pastures, further enhancing market confidence. Source: GlobeNewswire On April 14, the market expressed optimism about Allied Gaming & Entertainment's positive developments, leading to a significant increase in stock price during pre-market trading. Source: Public Technologies Industry trends are positive, with noticeable capital inflows. Immutep is up 68.11% in pre-market trading. Based on recent key news: On April 15, Immutep received FDA orphan drug designation for the treatment of soft tissue sarcoma. This designation supports potential late-stage development, with trials achieving primary endpoints in 38 evaluable patients, with a median tumor transparency/fibrosis of 51.5%. This news significantly boosted the stock price. On April 14, Immutep CEO Marc Voigt submitted an initial Form 3, showing ownership of 14,792,145 common shares. This news enhanced market confidence in the company's management, further driving the stock price up. On April 13, Immutep COO Deanne Diem Miller submitted an initial beneficial ownership statement, reporting ownership of 2,867,305 common shares This news also boosted market confidence in the company's management, driving the stock price up. There is increased market attention on the biotechnology sector, with significant capital inflows. Milestone Technology, pre-market up 41.54%, has no significant news recently. Trading is active, with clear capital flows. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation